We are looking for Canadian industry partners to fully exploit our R&D solutions. We transfer knowledge to our industry partners through patented technologies that have high potential commercial value — helping businesses develop cohesive, integrated and market-ready solutions that attract investment and drive revenue.

Express licensing

To provide easy access to some of Canada's leading technologies we make available cost-effective, non-exclusive, single-year, renewable research and development licenses according to a set of fixed terms and conditions.

Express licences (which are identified with the word Express in their titles below) are available at a rate of $1,000 Canadian per year, per listed technology for a specific business entity, or $750 Canadian per year, per listed technology for two or more technologies.

Select your industry category below to learn which NRC licensing opportunities can benefit your organization.

 

Filter options

Use these options to filter results

Published:
Topic: Licensing
Molecular electronics makes use of molecules as circuit elements. This new type of electronic component enables the possibility of extremely small devices and offers the prospect of a wider range of function than conventional semiconductors. These advantages stem from the unique transport mechanisms involved in nanoscale molecular transport, including ballistic transport. Ballistic carriers (electrons or holes) travel without scattering, and have excess energy relative to their surroundings. These features can be used to achieve desirable functions, including high-speed operation, chemical reactions, and excitation of light emission. This innovation offers the design of two- or three- terminal molecular electronic devices with ballistic transport.
Published:
Topic: Licensing
Transistors are the switches or gates for electronic signals. The smaller these are, the smaller the electronic devices can be. Innovations have led to the ability to miniaturize electronic devices to the smallest scale – individual molecules. Understandably, this building process has proven to be challenging. Improved gating strategies, increased knowledge on structure and control, and the ability to operate at room temperature are critical factors in determining the full potential of molecular electronic devices. This innovation describes the design of a molecular transistor capable of measuring electroconductivity on an electrostatically regulated atomic scale. The design considers a building process amenable to manufacturing and a variety of operating environments.
""
Published:
Topic: Licensing
To produce E1-deficient AV vectors without RCA contamination, NRC experts developed an A549 cell line suitable for research applications as well as clinical and commercial production. They have also developed a cell line to produce protease-deficient AV that contains the E1 region.
""
Published:
Topic: Licensing
Moraxella catarrhalis is a bacterium that can cause painful infection and inflammation of the middle ear, known medically as acute otitis media (AOM). Up to 75% of children will experience an AOM infection before age 5, while roughly 0.25% of adults develop AOM each year. Moraxella catarrhalis can also cause bacterial pneumonia and contributes to exacerbating existing chronic obstructive pulmonary disease (COPD).
Infections caused by Moraxella catarrhalis are often resistant to antibiotics such as penicillin, ampicillin, and amoxicillin. To prevent the painful infections that M. catarrhalis can cause and to address issues surrounding antimicrobial resistance, the NRC has engineered a vaccine candidate that can be licensed for further development, or advanced toward clinical trials in collaboration with our vaccine experts.
Published:
Topic: Licensing
Published:
Topic: Renewables - Solar Energy, Medical Technology, Electronic Devices, Semiconductors, Licensing
Published:
Topic: Electronic Devices, Semiconductors, Licensing
Published:
Topic: Licensing
Published:
Topic: Licensing, Biomaterials